ea0056p489 | Diabetes therapy | ECE2018
Linares Lidia Urbon Lopez de
, Soto Cristina Crespo
Diabetes is a chronic disease that is often accompanied by multiple comorbidities and health complications such as overweight/obesity. In the late years therapies improving glycemic control while reducing body weight have become a convenient choice to treat diabetes. One of those therapies are GLP 1 receptor agonists. Dulaglutide allows for a once weekly dosing which might improve compliance; moreover its new application device ease the injection. We show the results of HbA1c ...